Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT02328560
Eligibility Criteria:
Inclusion Criteria:
* 18 ≤ age \<75 years;
* WHO ≤ 1;
* Patients with cancer and candidate for chemotherapy treatment of first intention;
* Solid or lymphoid malignant disease pathology for which chemotherapy is given intravenously;
* Patient affiliated to a social security scheme;
* Mastery of the French language;
* Informed Consent and signed;
* In the first cohort, patients will have received paramedical consultation announcement in the days preceding the first cycle of chemotherapy;
* In the second cohort, patients have not received paramedical consultation announcement.
Exclusion Criteria:
* Patient deprived of liberty, under guardianship;
* Any medical or psychological condition associated that could compromise the patient's ability to participate in the study;
* Exclusive Oral Chemotherapy;
* Exclusive Targeted therapy;
* Targeted therapy to be introduced during chemotherapy;
* Presence of cerebral localization;
* Pain requiring analgesics bearing 3;
* Patient in medical and social structure;
* Inability to submit to medical monitoring test for geographical, social or psychological reasons;
* Rare Cancers making matching difficult (sarcomas of soft tissue and internal organs, malignant neuroendocrine tumors sporadic and hereditary rare ...)
* Inclusion in another clinical trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02328560
Study Brief:
Protocol Section:
NCT02328560